FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss REMs and Teratogenic Risk

[ Price : $8.95]

Federal Register Notice: FDAs Drug Safety and Risk Management Advisory Committee will meet 12/12 to discuss teratogenic risk, incl...

Public Citizen Wants Independent Probe of FDA Compounding Role

[ Price : $8.95]

Public Citizen calls for the HHS Inspector General to investigate FDAs failure to protect the public from the meningitis outbreak ...

Product Approvals Highlight CBER Annual Report

[ Price : $8.95]

CBER director Karen Midthun says the Center approved a number of new vaccines and other products during FY 2011.

FDA Updates NECC Consignee List

[ Price : $8.95]

FDA posts a corrected and updated list of New England Compounding Center customers who received product on or after 5/21.

Track and Trace Discussion Draft Floated on Hill

[ Price : $8.95]

House and Senate leaders float a pharmaceutical track and trace discussion draft that would require FDA to publish track and trace...

Amneal Wants Suboxone Petition Denied

[ Price : $8.95]

Amneal asks FDA to deny a Reckitt Benckiser petition seeking to require specific actions by companies pursuing ANDAs for generic S...

2 CDER Clinical Consultative MAPPs Issued

[ Price : $8.95]

CDER issues MAPPs on clinical consultative procedures for drugs regulated by the Office of New Drugs and for cancer drugs.

Temple Examines Predictive Enrichment in Clinical Trials

[ Price : $8.95]

CDER deputy center director for clinical science Robert Temple examines predictive enrichment in clinical trials that will be cove...

FDA Grants Priority Review to Ariad NDA for Leukemia

[ Price : $8.95]

FDA accepts an Ariad Pharmaceuticals NDA for accelerated and priority review for ponatinib for patients with chronic myeloid leuke...

Bayer Phase 3 Trial Meets Primary Endpoint in Pulmonary Hypertension

[ Price : $8.95]

Bayer HealthCare says the CHEST-1 Phase 3 trial met its primary endpoint in evaluating riociguat in patients with pulmonary hypert...